| Revenue growth | FY26 31.5% LFL; FY27 guided at 23% excluding new M&A. |
|---|---|
| Margins | Gross margin expanded 78bps to 10.3%; FY27 EBITDA target 5%. |
| Demand visibility | Strong organic momentum (15.6% vs IPM 1.6x). |
| Management confidence | High; delivered on all FY26 guidance parameters. |
Growth
FY26 revenue grew 31.5% LFL to ₹6,591cr; EBITDA margin reached 4% (+67bps YoY); PAT grew 36% YoY.
Outlook
FY27 guidance: 23% revenue growth (organic/calendarization) with 5% EBITDA margins; OCF conversion target of 50%.
Risks
Higher finance costs from debt-funded acquisitions; elevated depreciation from MedTech equipment rental models.
Earnings Call filed with BSE, BSE: 544122. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,733.10
- Market cap
- ₹7,543 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 60.1×Sector 53.1×
- Promoter holding
- 52.40%-0.02% QoQ
- FII holding
- 4.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Capital Structure Change
Surbhi Singh (Prasid Uno Family Trust), a non-promoter, sold 21.30 lakh Entero Healthcare shares via bulk/block deals. Stake fell from 7.94% to 3.05%; no transaction value disclosed.
Entero Healthcare Solutions Legal & Regulatory
Entero Healthcare Solutions reported a GST penalty of Rs. 0.13 Crore imposed on its subsidiary, ACE Cardiopathy Solutions, for non-generation of an E-Invoice.
- Value
- ₹0.13 Cr
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern for the period ended March 31, 2026, as per regulatory requirements.
Entero Healthcare Solutions Capital Structure Change
Prasid Uno Family Trust acquired 10,88,500 shares (2.50%) of Entero Healthcare Solutions Ltd via a block deal. Post-transaction, their total stake is 6.93%.
Entero Healthcare Solutions Management Change
Entero Healthcare Solutions announced the completion of the tenure of Non-Executive Independent Director Mr. Rajesh Shashikant Dalal, effective from August 24, 2026.
Entero Healthcare Solutions Annual General Meeting
Entero Healthcare Solutions Ltd held its 8th Annual General Meeting on August 19, 2026. Members approved all resolutions, including financial statement adoption and director re-appointments.